[Multicenter study on the effectiveness and tolerance of a bromazepam + propantheline combination in patients with irritable bowel syndrome].
D000293:Adolescent; D000328:Adult; D000368:Aged; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001960:Bromazepam / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003109:Colonic Diseases, Functional / Q000188:drug therapy* / Q000523:psychology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008347:Manifest Anxiety Scale; D008875:Middle Aged; D011413:Propantheline / Q000009:adverse effects / Q000627:therapeutic use*
D014151:Anti-Anxiety Agents; D011413:Propantheline; D001960:Bromazepam
Studio multicentrico sulla efficacia ela tollerabilità dell'associazione bromazepam + propantelina in pazienti con sindrome dell'intestino irritabile.